Featured Stories
Scientist Calls for Federal Regulations for Fracking Pollution

Scientist Calls for Federal Regulations for Fracking Pollution

Hydraulic fracturing (fracking) drilling should be governed by federal regulations because its pollution has no awareness of state boundaries.

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on behalf of a West Virginia man who developed bladder cancer ...

Read More

U.K. Regulators Issue Additional Guidance for Metal-on-Metal Hip Implant Recipients

U.K. Regulators Issue Additional Guidance for Metal-on-Metal Hip Implant Recipients

Regulators in the U.K. are once again issuing advice to doctors and other healthcare professionals involved in the follow-up of patients with metal-on-metal hip replacement devices. In an alert issued by the Medicines and Healthcare products Regulatory Agency (MHRA), guidance is provided for four groups of metal-on-metal hip implant ...

Read More

British Recall of Smith & Nephew Renasys Wound Care System

British Recall of Smith & Nephew Renasys Wound Care System for Infection Risk

The MHRA announced the recall of Smith & Nephew Renasys wound care devices - risk of maceration, infection, loss of negative pressure, or unrecognized bleeding in wounds.

Read More

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

A newly-published investigation from ProPublica has revealed that several questionable types of medical devices, including DePuy Orthopaedic’s recalled ASR hip implant, managed to make it to market without much scrutiny on the part of the U.S. Food & Drug Administration (FDA).

Read More

Lawsuit Alleges Plavix Caused Oklahoma Man to Suffer Multiple Stomach Bleeds

Lawsuit Alleges Plavix Caused Oklahoma Man to Suffer Multiple Stomach Bleeds

Another lawsuit has been filed over adverse Plavix side effects. The lawsuit, filed by national law firm Parker Waichman LLP, alleges that the blood thinner, Plavix (clopidogrel), caused an Oklahoma man to suffer from multiple stomach bleeds.

Read More

Sleep Aids Can Increase Alzheimer’s Risk

A new study has found that over-the-counter sleeping aids and anti-allergy medicines can increase the risk of Alzheimer’s disease.

The sleep medication Nytol and anti-allergy drug Benadryl are among the drugs highlighted in a warning from researchers. Each of these drugs has “anticholinergic” blocking effects on the nervous system that are said – at higher doses – to raise the likelihood of developing Alzheimer’s and other forms of dementia significantly over several years, The Guardian reports. Other drugs on the researchers’ list include “tricyclic” antidepressants and the bladder control treatment drug Ditropan (oxybutynin). Many of these medicines are taken by vulnerable older people. Continue reading

Posted in Health Concerns, Pharmaceuticals |

Trial over Ethicon Transvaginal Mesh Begins in California

Pelvic mesh devices have become the subject of safety concerns in recent years amidst reports that they can cause serious, sometimes permanent injuries. The devices were marketed to treat stress urinary incontinence and pelvic organ prolapse, but thousands of women allege that they only caused painful complications. According to The National Law Journal, a trial opened Monday in Bakerfield, California over a lawsuit alleging injuries from Ethicon’s TVT-Abbrevo pelvic mesh sling. Continue reading

Posted in Legal News |

J.J. Fuds, Inc. Pet Food Recalled Over Potential Listeria Contamination

Valparaiso, Indiana-based pet food manufacturer, J.J. Fuds, has recalled a specific lot of its J.J. Fuds Chicken Tender Chunks Pet Food over potential contamination with the dangerous, sometimes deadly, Listeria monocytogenes pathogen, according to the U.S. Food and Drug Administration (FDA).

The Listeria pathogen is unique because it thrives in colder temperatures, such as those found in refrigerated environments. Listeria also has an unusually long incubation period—up to 70 days—according to experts. The pathogen also well tolerates heat and dry temperatures, adding further challenges to the pathogen’s eradication and length to expected reporting time frames. Continue reading

Posted in Food Poisoning, Listeria |

Xarelto Mass Tort Organized in Philadelphia

Xarelto Mass Tort Organized in Philadelphia

Xarelto Mass Tort Organized in Philadelphia


Administrative Judge Kevin Dougherty of the Philadelphia Court of Common Pleas ordered the creation of a mass tort, transferring roughly 75 cases involving the blood thinner Xarelto to the court’s Complex Litigation Center.

The lawsuits are filed against Johnson & Johnson subsidiary Janssen Pharmaceuticals and Bayer HealthCare Pharmaceuticals. The lawsuits allege that Xarelto (rivaroxaban) causes uncontrollable and sometimes fatal bleeding, the Legal Intelligencer reports. An attorney representing several plaintiffs said Xarelto can cause “bleeding that cannot be stopped because there’s no antidote. The person can bleed to death or sustain serious injuries which could have been controlled in another product.” Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , , , |

Long Island Car Crash Kills 1 Person, Injures 2 More

Long Island Car Crash Kills 1 Person, Injures 2 More

Long Island Car Crash Kills 1 Person, Injures 2 More


A single-car accident on Long Island left one person dead and two more critically injured, Associated Press reports. The crash occurred at 4:30 a.m. Monday in Deer Park. Suffolk County Police have not yet determined the cause of the crash, but they say it was not a result of the weather.

The three occupants were in a 2003 Infiniti southbound on Straight Path when it swerved off the road and crashed into a tree south of Sagamore Lane. One of the occupants, a 28-year old man of Wyandanch, was ejected from the vehicle and pronounced dead at the scene. The other two occupants were also of Wyandanch. Police do not know who was the driving the car.

Posted in Legal News | Tagged , , , , |

Oil Spill into Yellowstone River Raises Concerns about Nation’s Aging Pipelines

Oil Spill into Yellowstone River Raises Concerns about Aging Pipelines

Oil Spill into Yellowstone River Raises Concerns about Aging Pipelines


As a community downstream from the January 17 Poplar Pipeline oil spill into the Yellowstone River works to treat benzene contamination of its water supply, concerns are being raised about oversight of the nation’s aging pipeline network.

Federal investigators and pipeline company officials were trying to determine the cause of the 40,000-gallon spill, which contaminated downstream water supplies in the city of Glendive, Montana, The Associated Press (AP) reports.  Continue reading

Posted in Benzene, Health Concerns, Oil Spills, Toxic Substances | Tagged , , , , , |

FDA-Approval Does Not Ensure Safety or Effectiveness of Drugs

FDA-Approval Does Not Ensure Safety/Effectiveness of Drugs

FDA-Approval Does Not Ensure Safety/Effectiveness of Drugs


When a drug is approved by the U.S. Food and Drug Administration (FDA), it may give some the impression that it is proven to be safe and effective for a certain condition. An investigation by the Milwaukee Journal Sentinel, however, shows that this is not necessarily true. By focusing on new diabetes drugs that have been on the market, the investigation suggests that FDA approval is no guarantee of safety or efficacy.

Diabetes medications such as Januvia, Byetta and Victoza were linked to 3,000 deaths and about 20,000 hospitalizations in the last decade. Furthermore, the report showed that none of the 30 new diabetes drugs have been shown to decrease the risk of key complications associated with the condition, such as heart attacks, stroke and blindness. Continue reading

Posted in Legal News | Tagged , , , , , |

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

Study Suggests Hormonal Contraceptives Linked to Brain Tumor

Study Suggests Hormonal Contraceptives Linked to Brain Tumor


A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.

Hormonal contraceptives, which contain female sex hormones, are commonly prescribed in pill form. “The Pill” first became widely available in the 1960s and gave women all over the world control over childbearing. The new study, which appeared in the British Journal of Clinical Pharmacology, reports that taking a hormonal contraceptive for at least five years is associated with a possible increase in the woman’s risk of developing a rare tumor, glioma of the brain, Science 2.0 reports.   Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , , |

British Health Agency Strengthens Warnings about Valproate Risk in Pregnancy

British Health Agency Strengthens Warnings about Valproate

British Health Agency Strengthens Warnings about Valproate


The Medicines and Healthcare Products Regulatory Agency (MHRA), Britain’s drug regulatory agency, has issued a statement urging healthcare professionals to give women better information on the risk of birth defects when Depakote and other valproate medicines are used during pregnancy. These medications are used to treat epilepsy and bipolar disorder.

Following a European review last year, which found that up to 40 percent of children born to women who take valproate during pregnancy may have developmental disorders and other birth defects, MHRA moved to strengthen product information. The agency is making informational booklets available to healthcare professionals and patients and the leaflet in the drug packing is being updated with stronger warnings about the risk of developmental disorders in children exposed to valproate during pregnancy. The review found that of 35,000 women prescribed valproate, 375 become pregnant per year while taking it. Continue reading

Posted in Birth Defects, Depakote, Health Concerns, Pharmaceuticals | Tagged , , , , , |

Whistleblower Wins Retaliation Lawsuit

Whistleblower Wins Retaliation - Canaveral National Seashore

Whistleblower Wins Retaliation – Canaveral National Seashore


A whistleblower who reported misconduct at Canaveral National Seashore has won a retaliation ruling against the U.S. Department of Interior, Florida Today reports. The former employee filed a suit in 2011 alleging misconduct, including contracting violations and nepotism. Continue reading

Posted in Legal News | Tagged , , , , |

© 2005-2014 Parker Waichman LLP ®. All Rights Reserved.